Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?

Fraint, Avram; Vittal, Padmaja; Comella, Cynthia

Fraint, Avram; Vittal, Padmaja; Comella, Cynthia.

Afiliación

Fraint A; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Vittal P; Section of Movement Disorders, Rush University Medical Center, Chicago, IL, USA.
Comella C; Section of Movement Disorders, Rush University Medical Center, Chicago, IL, USA.

Ther Clin Risk Manag ; 12: 147-54, 2016.

Article en En | MEDLINE | ID: mdl-26917963

Palabras clave

BoNT; abobotulinumtoxin A; botulinum toxin; incobotulinumtoxin A; onabotulinumtoxin A; rimabotulinumtoxin B

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Ther Clin Risk Manag Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google